Kecheng Xu

Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer

Yan Xu, Zheng Xiang, Mohammed Alnaggar et al. · Cellular and Molecular Immunology · 2020 · 251 citations · Full text

Life Sciences, Immunology, Oncology +17

Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma

Mohammed Alnaggar, Yan Xu, Jingxia Li et al. · Journal for ImmunoTherapy of Cancer · 2019 · 128 citations · Full text

Medicine, Immunology, Oncology +14

Combination Treatment With Comprehensive Cryoablation and Immunotherapy in Metastatic Pancreatic Cancer

Lizhi Niu, Jibing Chen, Lihua He et al. · Pancreas · 2013 · 86 citations

Medicine, Oncology, Immunotherapy +12

Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer

Mao Lin, Shuzhen Liang, Xiaohua Wang et al. · Immunologic Research · 2017 · 67 citations

Medicine, Immunology, Oncology +11

A pilot study on combination of cryosurgery and 125iodine seed implantation for treatment of locally advanced pancreatic cancer

Kecheng Xu, Lizhi Niu, Yize Hu et al. · World Journal of Gastroenterology · 2008 · 65 citations · Full text

Medicine, Oncology, Surgery +17